Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
A small, secret panel of experts have been tasked with reviewing crucial data of coronavirus vaccines that U.S. taxpayers have helped fund.
An estimated 60% of Republicans and 46% of Democrats say they wouldn’t get inoculated if a vaccine was available.
Some scientists are investigating how the virus enters humans cells, developing more efficient testing and searching for treatments.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Public health departments are now being told to prepare to distribute COVID-19 vaccines as early as November 1.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
We’re all familiar with vaccines that prime the immune system to prevent infections. Can a similar approach be used to fight cancer?
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
Life expectancy in some regions of the country grew by four years from 2001 to 2014, while it shrank by two years in others.
Measles seldom crossed paths with cancer survivors, but now that may change.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.